SpyGlass Pharma, Inc. (SGP) Reports Q1 Loss of $0.69

SpyGlass Pharma, Inc. (NASDAQ: SGP) reported Q1 EPS of ($0.69).Revenue for the quarter came in at $0 .

For earnings history and earnings-related data on SpyGlass Pharma, Inc. (SGP) click here.

You May Also Be Interested In

• UBS Assumes Interactive Brokers Group (IBKR) at Neutral, 'A Best-in-Class, Yet Fairly Valued Brokerage'
• Goldman Sachs sees refinery exemptions boosting DK cash flow
• Science Applications (SAIC) PT Raised to $154 at Stifel